Aging of the population, the emergence of novel contagious diseases and the transition from conventional treatment-centered practices to early diagnosis and prevention are accelerating the growth of in-vitro diagnostic devices. With the progress of medical and biotechnology, classic microbiological and chemical-clinical diagnostics are giving way to electronic engineering, IT, materials and mechanical engineering technology convergence.
As a consequence, experts with knowledge in biotechnology as well as the mechanical and IT technology which enable their application are needed to properly comprehend and suitably protect in-vitro diagnostic technologies.
Aging of the population, the emergence of novel contagious diseases and the transition from conventional treatment-centered practices to early diagnosis and prevention are accelerating the growth of in-vitro diagnostic devices. With the progress of medical and biotechnology, classic microbiological and chemical-clinical diagnostics are giving way to electronic engineering, IT, materials and mechanical engineering technology convergence.
As a consequence, experts with knowledge in biotechnology as well as the mechanical and IT technology which enable their application are needed to properly comprehend and suitably protect in-vitro diagnostic technologies.
Given the technology gap between the Korean bio industry and those of Europe and the U.S., the Korean bio industry has made few overseas forays, and has had only limited success in technology commercialization. As a result, there are few domestic experts who understand the importance of and are professionally trained in appropriate IP creation and portfolio-building.
While Korean bio firms have focused on IP creation as the outcome of R&D, the true value of IP lies in protection of technology and licensing feasibility.
That is to say, the crucial question is whether or not an enterprise’s IP sufficiently protects future products and preempts copycat attempts by competitors. Advice from an expert who understands the importance of this from the technology development phase onwards is critical.
BLT's bio patent experts have worked with overseas bio firms including Roche and Genentech, and have extensive experience in domestic and overseas IP disputes, licensing and IP application filing strategy, as well as know-how in optimal protection for bio technology.
Given the technology gap between the Korean bio industry and those of Europe and the U.S., the Korean bio industry has made few overseas forays, and has had only limited success in technology commercialization. As a result, there are few domestic experts who understand the importance of and are professionally trained in appropriate IP creation and portfolio-building. While Korean bio firms have focused on IP creation as the outcome of R&D, the true value of IP lies in protection of technology and licensing feasibility. That is to say, the crucial question is whether or not an enterprise’s IP sufficiently protects future products and preempts copycat attempts by competitors. Advice from an expert who understands the importance of this from the technology development phase onwards is critical.
BLT's bio patent experts have worked with overseas bio firms including Roche and Genentech, and have extensive experience in domestic and overseas IP disputes, licensing and IP application filing strategy, as well as know-how in optimal protection for bio technology.
Managing Partner (patent attorney and lawyer)
Yeonsoo ParkManaging Partner (patent attorney and lawyer)
Managing Partner
Taekyun ChungManaging Partner
Managing Partner
Sunghyun KimManaging Partner
Managing Partner
Ilhyo SuhManaging Partner
Request for professional consultation
Request for professional consultation
Head Office 1F, 25, Beobwon-ro 3-gil, Seocho-gu, Seoul, 06595 Republic of Korea
Tel : +82-2-514-0104 Fax : +82-70-4855-0102 Email : info@blt.kr
Incheon Office 26F, 165, Convensia-daero (POSCO Tower Building), Yeonsu-gu, Incheon (Stage9 Songdo POSCO Tower)
Tel : +82-32-710-5104 Fax : +82-70-4855-0102 Email : info@blt.kr
ⓒ 2023. BLT Patent & Law Firm All Rights Reserved.
Head Office 1F, 25, Beobwon-ro 3-gil, Seocho-gu, Seoul, 06595 Republic of Korea
Tel : +82-2-514-0104 Fax : +82-70-4855-0102 E : info@blt.kr
Incheon Office 26F, 165, Convensia-daero (POSCO Tower Building), Yeonsu-gu, Incheon (Stage9 Songdo POSCO Tower)
Tel : +82-32-710-5104 Fax : +82-70-4855-0102 Email : info@blt.kr
ⓒ 2023. BLT Patent & Law Firm All Rights Reserved.
